Trial Information

Do you, or does your child have asthma? The study is a clinical research study being conducted worldwide. The study is comparing a medication which is a combination of two differenct drugs (fluticasone propionate and salmeterol) to a medication that has only one drug (fluticasone propionate alone). Both the combination drug and fluticasone propionate alone are currently available by prescription outside this clinical research study.

A 6-Month Safety and Benefit Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old with Persistent Asthma

Patient Inclusion Criteria:

Are 12 years of age or older
Have had asthma for at least one year.
Are receiving asthma treatment.
Have had asthma bad enough to see a doctor in the last 12 months that required treatment with steroids such as prednisone or Medrol pack. Have you had such a flair up?
Take any of the following asthma medications: Advair, Pulmicort, Symbicort, Dulera, Flovent, Qvar, Alvesco, Azmacort, Aerobid, Asmanex.

Patient Exclusion Criteria:

Have been hospitalized for asthma more than 2 times in the last year.
Have had a tube put down your throat to help you breathe because of your asthma.
Have you smoked for longer than 5 years?
Have lung problems other than asthma.

Michelle Sowell, Director of Operations
Clinical Research Atlanta
175 Country Club Drive
Suite 100 A
Stockbridge, GA 30281
Phone: 770-507-6867
Fax: 770-507-1539+
Email: msowell@clinicalresearchatlanta.com

View Map

Research Center Information: Clinical Research Atlanta

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.